8 October 2026
Experts say South Africa should track medicine shortages by whether patients get full treatment on time, not by stock figures alone.
8 September 2026
The 2025 Mediscor Medicines Review shows medicine spend up 4.7%, with generics, chronic care and speciality drugs shaping affordability.
25 August 2026
GLP-1 generics could cut obesity drug costs, challenge illegal sales and expand access as more semaglutide products seek approval.
27 July 2026
Aspen HIV prevention pill licensing deal positions the SA manufacturer to supply lower-cost monthly PrEP across key African markets.
23 July 2026
Generic drug tariffs could raise US medicine costs, disrupt global supply chains and pressure manufacturers to move production to America.
16 July 2026
Sun Pharma’s Generic Semaglutide is now available in South Africa. Explore this new treatment option for type 2 diabetes.
9 July 2026
Slow patent reform is blocking access to lifesaving medicines in South Africa, affecting public healthcare and affordability.
10 June 2026
The lenacapavir HIV Prevention Injection rollout begins in SA, but activists warn that limited supply from Gilead could blunt the impact.
23 March 2026
Learn how the advent of Generic Semaglutide in India will change the landscape of weight-loss and diabetes medications.
9 February 2026
Discover how healthcare investment drives growth, linking public health to stronger GDP performance in emerging markets.
15 September 2025
Dive into the Mediscor medicines review 2024 to understand the complexities of rising medicine costs and healthcare sustainability.
28 October 2024
As demand for budget-friendly health solutions grows, Clicks CEO Bertina Engelbrecht emphasised the group’s commitment to offering more affordable alternatives.